Dendrimer Heparan Sulfate Glycomimetics: Potent Heparanase Inhibitors for Anticancer Therapy

Olga V. Zubkova, Yassir Ahmed, Scott E. Guimond, Sophia‐Louise Noble, John H. Miller, Raymond A. Smith, Victor Nurcombe, Peter C. Tyler, Marina Weissmann, Israël Vlodavsky,

ACS Chemical Biology · 2018 · 60 citations · 29 references

DOIFull text

Open access

Concepts

Abstract

potency for heparanase inhibition equivalent to comparator compounds in clinical development, and potently inhibit metastasis and growth of human myeloma tumor cells in a mouse xenograft model. Importantly, they lack anticoagulant activity and cytotoxicity, and also inhibit angiogenesis. They provide a new candidate class for anticancer and wider therapeutic applications, which could benefit from targeted heparanase inhibition.

References

29